Laurel Oak Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$249K Sell
645
-251
-28% -$93.1K 0.04% 316
2026
Q1
$262K Sell
896
-71
-7% -$23.3K 0.04% 296
2025
Q4
$339K Buy
+967
New +$327K 0.06% 244

Other funds holding ELV

Laurel Oak Wealth Management's ELV Position: Q2 2026 in Review

Laurel Oak Wealth Management reduced its Elevance Health (ELV) stake by 28% in Q2 2026, selling an estimated $93.1K and leaving 645 shares worth $249K. The position accounts for 0.04% of the portfolio, ranked #316.

Laurel Oak Wealth Management first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. The position peaked at $339K in Q4 2025. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Laurel Oak Wealth Management held 645 shares of Elevance Health worth $249K as of Q2 2026.
  • Laurel Oak Wealth Management sold 251 Elevance Health shares in Q2 2026, an estimated $93.1K.
  • Elevance Health made up 0.04% of Laurel Oak Wealth Management's portfolio in Q2 2026, its #316 holding.
  • Laurel Oak Wealth Management first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
  • Laurel Oak Wealth Management's Elevance Health position peaked at $339K in Q4 2025.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Laurel Oak Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.